Explore it now
27th Annual ESGO 2026 Congress
Discover it Now!
ENGOT coordinates and promotes gynaecological cancer clinical trials in Europe
Explore ENGOT
Explore ESGO’s Membership Benefits
Read More
Get ready for an exclusive 4-part webinar series diving into the latest ESGO-ESTRO-ESP Endometrial Cancer Guidelines update expected to be released this Spring! Led by world-renowned experts who shaped these updated recommendations together with an international multidisciplinary team of 30 experts and 225 reviewers, this upcoming webinar series will provide practical insights, case-based discussions, and expert guidance on risk stratification, molecular classification, surgical approaches, and advanced treatment strategies.
The recent revision of the ESGO ESTRO ESP guidelines underscores the importance of a multidisciplinary approach, ensuring that endometrial cancer is addressed from every critical angle—from diagnosis to treatment and, ultimately, patient care. Join us online to learn more about these updates from the guidelines chairs!
“The updated FIGO staging system, which incorporates both molecular and anatomical factors, represents a significant step forward in refining prognostic assessment and treatment planning for endometrial cancer.Don’t miss this opportunity to gain valuable insights into the Triple European Endometrial Cancer Guidelines, covering risk group stratification, molecular classification & biomarkers, pathological features, surgical cornerstones, adjuvant treatment, and the management of metastatic and recurrent disease!" Nicole Concin
Co-Chairs: Nicole Concin, Austria, Xavier Matias-Guiu Guia, Spain, Remi Nout, The Netherlands
Speakers: Nicoletta Colombo, Antonio Gonzáles-Martin, Carien Creutzberg
Speakers: Christian Marth, Domenica Lorusso, Gabriella Macchia
This 90-minute webinar will include insightful presentations from a diverse panel of speakers addressing key clinical questions, including:
+ When should molecular testing be performed? + What are the most critical markers for guiding treatment decisions? Why do they matter? + How does the new FIGO staging impact clinical practice?
Co-Chairs: Nicole Concin, Austria, Xavier Matias-Guiu Guia, Spain, Remi Nout, The Netherlands Special guest: Sarikapan Wilailak
Speakers: Tjalling Bosse, Francesco Fanfani
Webinar Programme: + Overview of the New ESGO-ESTRO-ESP Guidelines Nicole Concin, Austria + Molecular Risk Groups in Endometrial Cancer Remi Nout, The Netherlands + Molecular & Histopathological Markers in Risk Stratification Xavier Matias-Guiu Guia, Spain, and Tjalling Bosse, The Netherlands + LVSI in Endometrial Cancer: Pathological & Clinical Perspectives Tjalling Bosse, The Netherlands, and Francesco Fanfani, Italy
Speakers: Anna Fagotti, David Cibula, and Christina Fotopoulou
Webinar Topics: + Surgery for Early-Stage Endometrial Cancer + Lymph Node Staging in Endometrial Cancer + Surgical Management of Relapsed and Advanced Endometrial Cancer
Webinar Co-Chair: Nicole Concin, Austria Professor of Gynaecology at MedUni Vienna and Head of the Division of General Gynaecology and Gynaecological Oncology at the Department of Obstetrics and Gynaecology of MedUni Vienna and University
Webinar Co-Chair: Xavier Matias-Guiu Guia, Spain Professor of Pathology at the University of Barcelona and Lleida, President-Elect of the European Society of Pathology (ESP), and co-chair of the ESGO-ESTRO-ESP Guidelines.
Webinar Co-Chair: Remi Nout, The Netherlands Head of the Radiation Oncology department at Erasmus University Medical Center Rotterdam, the Netherlands, and the representative of ESTRO in the multidisciplinary management guidelines for the treatment of women with endometrial cancer. Within ESTRO, leading the initiation of the gynaecological cancer focus group, and co-director of the ESTRO teaching course for gynaecological cancer.